Curcumin-Piperlongumine Hybrids with a Multitarget Profile Elicit Neuroprotection in In Vitro Models of Oxidative Stress and Hyperphosphorylation
Authors:
- Ángel CoresÁngel Cores
- Noelia Carmona-ZafraNCNoelia Carmona-Zafra
- Olmo Martín-CámaraOMOlmo Martín-Cámara
- Juan Domingo SánchezJSJuan Domingo Sánchez
- Pablo DuartePDPablo Duarte
- Mercedes VillacampaMercedes Villacampa
- Paloma Bermejo-BescósPBPaloma Bermejo-Bescós
- Sagrario Martín-AragónSMSagrario Martín-Aragón
- Rafael LeónRafael León
- J. Carlos MenéndezJ. Carlos Menéndez
Open Access
- 24 December 2021
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 11 (1) , 28
Abstract
Curcumin shows a broad spectrum of activities of relevance in the treatment of Alzheimer’s disease (AD); however, it is poorly absorbed and is also chemically and metabolically unstable, leading to a very low oral bioavailability. A small library of hybrid compounds designed as curcumin analogues and incorporating the key structural fragment of piperlongumine, a natural neuroinflammation inhibitor, were synthesized by a two-step route that combines a three-component reaction between primary amines, β-ketoesters and α-haloesters and a base-promoted acylation with cinnamoyl chlorides. These compounds were predicted to have good oral absorption and CNS permeation, had good scavenging properties in the in vitro DPPH experiment and in a cellular assay based on the oxidation of dichlorofluorescin to a fluorescent species. The compounds showed low toxicity in two cellular models, were potent inductors of the Nrf2-ARE phase II antioxidant response, inhibited PHF6 peptide aggregation, closely related to Tau protein aggregation and were active against the LPS-induced inflammatory response. They also afforded neuroprotection against an oxidative insult induced by inhibition of the mitochondrial respiratory chain with the rotenone-oligomycin A combination and against Tau hyperphosphorylation induced by the phosphatase inhibitor okadaic acid. This multitarget pharmacological profile is highly promising in the development of treatments for AD and provides a good hit structure for future optimization efforts.Keywords
Funding Information
- Ministerio de Ciencia e Innovación, Spain (RTI2018-097662-B-I00)
This publication has 83 references indexed in Scilit:
- Neuroprotective effect of curcumin on okadaic acid induced memory impairment in miceEuropean Journal of Pharmacology, 2013
- Towards a Pharmacophore for AmyloidPLOS Biology, 2011
- Modulation of ROS/MAPK signaling pathways by okadaic acid leads to cell death via, mitochondrial mediated caspase-dependent mechanismApoptosis, 2010
- Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike PropertiesACS Chemical Neuroscience, 2010
- CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fieldsJournal of Computational Chemistry, 2009
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human SubjectsCancer Epidemiology, Biomarkers & Prevention, 2008
- Prediction of Nucleating Sequences from Amyloidogenic Propensities of Tau-Related PeptidesBiochemistry, 2006
- Microglia: Intrinsic immuneffector cell of the brainBrain Research Reviews, 1995
- Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stressChemical Research in Toxicology, 1992